We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$11.4B
AUM Growth
+$476M
Cap. Flow
-$300M
Cap. Flow %
-2.64%
Top 10 Hldgs %
22.33%
Holding
2,538
New
224
Increased
309
Reduced
1,136
Closed
102

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.1M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$21.3M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$13.2M
4
PATH icon
UiPath
PATH
+$10.4M
5
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$4.67M

Top Sells

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$20.7M
2
AAPL icon
Apple
AAPL
+$16M
3
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$15.6M
4
MSFT icon
Microsoft
MSFT
+$13M
5
WMB icon
Williams Companies
WMB
+$9.28M

Sector Composition

Rank Sector Weight
1 Technology 20.93%
2 Financials 13.29%
3 Healthcare 12.64%
4 Consumer Discretionary 11.46%
5 Industrials 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALTA
1876
DELISTED
Altabancorp
ALTA
$304K ﹤0.01%
7,011
– –
INSG icon
1877
Inseego
INSG
$78M
$304K ﹤0.01%
3,009
+1,447
+93% +$132K
OFIX icon
1878
Orthofix Medical
OFIX
$414M
$304K ﹤0.01%
7,567
– –
WNC icon
1879
Wabash National
WNC
$509M
$303K ﹤0.01%
18,960
+4,237
+29% +$72.7K
CPF icon
1880
Central Pacific Financial
CPF
$1B
$303K ﹤0.01%
11,636
– –
RNAM
1881
DELISTED
Avidity Biosciences
RNAM
$303K ﹤0.01%
12,243
– –
ARCT icon
1882
Arcturus Therapeutics
ARCT
$224M
$302K ﹤0.01%
8,939
– –
CARM
1883
DELISTED
Carisma Therapeutics
CARM
$302K ﹤0.01%
+3,273
New +$209K
DOCN icon
1884
DigitalOcean
DOCN
$15.5B
$302K ﹤0.01%
+5,427
New +$234K
RYTM icon
1885
Rhythm Pharmaceuticals
RYTM
$7.98B
$301K ﹤0.01%
15,372
– –
NEX
1886
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$301K ﹤0.01%
63,217
+27,783
+78% +$122K
PETS icon
1887
PetMed Express
PETS
$43.8M
$301K ﹤0.01%
9,436
– –
PFBC icon
1888
Preferred Bank
PFBC
$1.28B
$300K ﹤0.01%
4,747
-1,826
-28% -$121K
SMP icon
1889
Standard Motor Products
SMP
$870M
$300K ﹤0.01%
6,921
-2,717
-28% -$122K
CTRN icon
1890
Citi Trends
CTRN
$621M
$299K ﹤0.01%
3,442
– –
SLP icon
1891
Simulations Plus
SLP
$370M
$299K ﹤0.01%
5,451
– –
TRTX
1892
TPG RE Finance Trust
TRTX
$616M
$298K ﹤0.01%
22,167
+7,085
+47% +$90.8K
FMTX
1893
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$297K ﹤0.01%
11,944
– –
VIEW
1894
DELISTED
View, Inc. Class A Common Stock
VIEW
$297K ﹤0.01%
+583
New +$286K
HCC icon
1895
Warrior Met Coal
HCC
$4.98B
$296K ﹤0.01%
17,236
-6,487
-27% -$113K
RMAX icon
1896
RE/MAX Holdings
RMAX
$267M
$296K ﹤0.01%
8,877
– –
CRMT icon
1897
America's Car Mart
CRMT
$25.8M
$296K ﹤0.01%
2,086
– –
NIC icon
1898
Nicolet Bankshares
NIC
$3.73B
$295K ﹤0.01%
4,200
– –
ARCH
1899
DELISTED
Arch Resources, Inc.
ARCH
$295K ﹤0.01%
5,183
-1,982
-28% -$104K
CHRS icon
1900
Coherus Oncology
CHRS
$176M
$295K ﹤0.01%
21,324
– –
74 75
76
77 78

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

MetLife Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, MetLife Investment Management held 2,538 positions worth $11.4B, up 4.4% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management's Q2 2021 filing shows 224 new, 309 increased, 1,136 reduced and 102 closed positions. Its largest new stake was UiPath: 142,126 shares worth $9.65M. The largest sale was MPLX, an estimated $20.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q2 2021 buy was UiPath: 142,126 shares worth $9.65M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $24.1M increase.
  • MetLife Investment Management's biggest Q2 2021 reduction was Apple, cutting an estimated $16M.
  • MetLife Investment Management fully exited MPLX in Q2 2021, selling an estimated $20.7M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $11.4B portfolio in Q2 2021.
  • MetLife Investment Management opened 224 new positions and closed 102 in Q2 2021.
  • MetLife Investment Management's portfolio value rose 4.4% quarter-over-quarter to $11.4B.

Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.